The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(N-(2-(4-(2-(4-((3-carbamoylphenyl)amino)-4-oxobutanamido)ethyl)-1H-1,2,3-triazol-1-yl)ethyl)sulfamoyl)benzoic acid ID: ALA5205408
Cas Number: 2084811-68-5
PubChem CID: 122707115
Product Number: H288586, Order Now?
Max Phase: Preclinical
Molecular Formula: C24H27N7O7S
Molecular Weight: 557.59
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)c1cccc(NC(=O)CCC(=O)NCCc2cn(CCNS(=O)(=O)c3cccc(C(=O)O)c3)nn2)c1
Standard InChI: InChI=1S/C24H27N7O7S/c25-23(34)16-3-1-5-18(13-16)28-22(33)8-7-21(32)26-10-9-19-15-31(30-29-19)12-11-27-39(37,38)20-6-2-4-17(14-20)24(35)36/h1-6,13-15,27H,7-12H2,(H2,25,34)(H,26,32)(H,28,33)(H,35,36)
Standard InChI Key: MUOMSHSMJCWQFH-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 41 0 0 0 0 0 0 0 0999 V2000
-6.7541 -1.5129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0395 -1.1007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3277 -1.5127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3277 -2.3378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0378 -2.7496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.7541 -2.3416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4687 -1.1005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.1834 -1.5129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.4687 -0.2753 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.6130 -1.1000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8984 -1.5127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1837 -1.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8984 -2.3378 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4691 -1.5127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7545 -1.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0398 -1.5127 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7545 -0.2749 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3252 -1.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3893 -1.5127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1040 -1.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1902 -0.2799 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9970 -0.1083 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4094 -0.8226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8575 -1.4356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2346 -0.8226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6472 -0.1080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4723 -0.1080 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8850 0.6066 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.7101 0.6066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1230 1.3211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9457 1.3203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3584 0.6055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9492 -0.1063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1245 -0.1110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8850 1.4333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1708 1.0200 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3583 2.0350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1834 2.0350 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9457 2.7496 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
1 7 1 0
7 8 1 0
7 9 2 0
3 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
16 18 1 0
18 19 1 0
19 20 1 0
21 20 1 0
21 22 2 0
22 23 1 0
23 24 1 0
24 20 2 0
23 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
30 29 2 0
31 30 1 0
32 31 2 0
33 32 1 0
34 33 2 0
29 34 1 0
28 35 2 0
28 36 2 0
37 31 1 0
37 38 1 0
37 39 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 557.59Molecular Weight (Monoisotopic): 557.1693AlogP: 0.13#Rotatable Bonds: 14Polar Surface Area: 215.47Molecular Species: ACIDHBA: 9HBD: 5#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 3.75CX Basic pKa: 0.34CX LogP: -0.32CX LogD: -3.61Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.18Np Likeness Score: -1.84
References 1. Nizi MG, Maksimainen MM, Lehtiö L, Tabarrini O.. (2022) Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules., 65 (11.0): [PMID:35608571 ] [10.1021/acs.jmedchem.2c00281 ]